Detalhe da pesquisa
1.
Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
J Cell Physiol
; 235(1): 573-586, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31245853
2.
The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.
Exp Cell Res
; 330(1): 199-211, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25447310
3.
Vitamin D Control of Hematopoietic Cell Differentiation and Leukemia.
J Cell Biochem
; 116(8): 1500-12, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25694395
4.
ERK5 pathway regulates transcription factors important for monocytic differentiation of human myeloid leukemia cells.
J Cell Physiol
; 229(7): 856-67, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24264602
5.
Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D3.
Exp Cell Res
; 317(1): 117-30, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20804750
6.
Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors.
Hematol Oncol
; 28(3): 124-32, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19866452
7.
Primary central nervous system marginal zone B-cell lymphoma arising from the dural meninges: A case report and review of literature.
Clin Case Rep
; 8(3): 491-497, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32185043
8.
Autoimmune Diseases and Rosai-Dorfman Disease Coexist More Commonly than Expected: Two Case Reports.
Am J Case Rep
; 20: 770-772, 2019 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147530
9.
Large granular lymphocytic leukemia complicating autoimmune polyglandular syndrome type 1 in siblings.
Clin Case Rep
; 6(5): 847-850, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29744070
10.
JNK1 as a signaling node in VDR-BRAF induction of cell death in AML.
J Steroid Biochem Mol Biol
; 177: 149-154, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765039
11.
The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 5' flanking region of neurokinin-2 receptor.
Cell Signal
; 18(4): 422-32, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16009534
12.
BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.
J Steroid Biochem Mol Biol
; 173: 139-147, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27637326
13.
Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
Blood Coagul Fibrinolysis
; 28(4): 342-347, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27676646
14.
The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Oncotarget
; 7(24): 36447-36460, 2016 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27144333
15.
Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
J Steroid Biochem Mol Biol
; 164: 72-78, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319201
16.
The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway.
J Steroid Biochem Mol Biol
; 97(1-2): 47-55, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16046262
17.
Stomatocytosis heralding a case of acute Wilsonian crisis.
Ann Hematol
; 89(5): 527-9, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19777232
18.
Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter.
J Neuroimmunol
; 138(1-2): 65-75, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12742655
19.
Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P.
Regul Pept
; 111(1-3): 169-78, 2003 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12609765
20.
The neuronal cyclin-dependent kinase 5 activator p35Nck5a and Cdk5 activity in monocytic cells.
Leuk Lymphoma
; 44(2): 235-40, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12688339